Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats
Phytochemical Analysis · 04.11.2026
DOI: 10.1002/pca.70097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemical Analysis, online erschienen am 04.11.2026. Verfasst von Yihang Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Zhejiang Traditional Chinese Medicine Administration, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Guanxinshutong capsule (GXST), derived from Mongolian medicine, is widely used for coronary heart disease. However, the influence of gut microbiota on the bioavailability of its major components remains unknown. This study compared the impact of gut microbiota on the pharmacokinetics of GXST's major components.
Methods
Plasma samples were collected from normal and broad‐spectrum antibiotic (ABX)‐pretreated rats after oral GXST administration. An ultrahigh performance liquid chromatography‐mass spectrometry (UHPLC–MS) method was established and validated (specificity, stability, recovery, and matrix effect) to quantify nine major components. Pharmacokinetic parameters were fitted using a non‐compartmental model.
Results
The validated UHPLC–MS method met analytical criteria. Gut microbiota notably influenced the bioavailability of ellagic acid, ferulic acid, salvianolic acid B, tricin, cryptotanshinone, and tanshinone IIA. Relative bioavailabilities (normal/ABX‐pretreated) were ellagic acid 69.9%, ferulic acid 38.3%, salvianolic acid B 44.3%, tricin 51.6%, cryptotanshinone 144.2%, and tanshinone IIA 81.6%. Notably, the relative bioavailabilities of ferulic acid, salvianolic acid B, and tricin were reduced by approximately 50%.
Conclusions
A sensitive UHPLC–MS method for simultaneous quantification of nine GXST components in rat plasma was validated. These findings provide new insights for pharmacokinetic studies of Traditional Chinese Medicine (TCM) and natural products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhejiang Chinese Medical University, Hangzhou, China.
- Zhejiang Key Laboratory of Chinese Medicine for Cardiovascular and Cerebrovascular Disease, Hangzhou, China.
- Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, China.
ORCID-Profile: Chang Li
Förderung
- National Key Research and Development Program of China
- Zhejiang Traditional Chinese Medicine Administration
- National Natural Science Foundation of China
Zitieren
APA
Lu, Y., Wang, X., Wang, X., He, Y., Yang, J., Li, C., & Wan, H. (2026). Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats. Phytochemical Analysis. https://doi.org/10.1002/pca.70097
Vancouver
Lu Y, Wang X, Wang X, He Y, Yang J, Li C, et al. Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats. Phytochemical Analysis. 2026. doi:10.1002/pca.70097
BibTeX
@article{Lu2026,
author = {Lu, Yihang and Wang, Xiaoya and Wang, Xinmeng and He, Yu and Yang, Jiehong and Li, Chang and Wan, Haitong},
title = {Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats},
journal = {Phytochemical Analysis},
year = {2026},
doi = {10.1002/pca.70097}
}
EUVIMED